This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Imai, H. Articles by Macrae, I. M. Search for Related Content PubMed PubMed Citation Articles by Imai, H. Articles by Macrae, I. M. Related Collections Animal models of human disease Neuroprotectors Other Stroke Treatment - Medical Oxidant stress

(Stroke. 2001;32:2149.)
© 2001 American Heart Association, Inc.

Original Contributions

Ebselen Protects Both Gray and White Matter in a Rodent Model of Focal Cerebral Ischemia

H. Imai, MD, PhD; H. Masayasu, PhD; D. Dewar, PhD; D. I. Graham, MB, PhD I. M. Macrae, PhD

From Wellcome Surgical Institute and Department of Neuropathology, University of Glasgow (H.I., D.D., D.I.G., I.M.M.), Glasgow, Scotland, and Daiichi Pharmaceutical Co Ltd (H.M.), Tokyo, Japan.

Correspondence to Dr I. Mhairi Macrae, Wellcome Surgical Institute and Hugh Fraser Neuroscience Laboratories, University of Glasgow, Garscube Estate, Bearsden Road, Glasgow G61 1QH, Scotland, UK. E-mail mhairi.macrae{at}udcf.gla.ac.uk

Background and Purpose—— The neuroprotective efficacy of an intravenous formulation of the antioxidant ebselen has been comprehensively assessed with specific regard to conventional quantitative histopathology, subcortical axonal damage, neurological deficit, and principal mechanism of action.

Methods—— Transient focal ischemia (2 hours of intraluminal thread-induced ischemia with 22 hours of reperfusion) was induced in the rat. Ebselen (1 mg/kg bolus plus 1 mg/kg per hour IV) or vehicle was administered at the start of reperfusion and continued to 24 hours. Neurological deficit was assessed 24 hours after ischemia. Gray matter damage was evaluated by quantitative histopathology. Axonal damage was determined with amyloid precursor protein immunohistochemistry used as a marker of disrupted axonal flow and Tau-1 immunohistochemistry to identify oligodendrocyte pathology. Oxidative damage was determined by 8-hydroxy-2'-deoxyguanosine (8-OHdG) and 4-hydroxynonenal (4-HNE) immunohistochemistry.

Results—— Ebselen significantly reduced the volume of gray matter damage in the cerebral hemisphere (by 53.6% compared with vehicle, P<0.02). Axonal damage was reduced by 46.8% (P<0.002) and the volume of oligodendrocyte pathology was reduced by 60.9% (P<0.005). The neurological deficit score was reduced by 40.7% (P<0.05) and the volume of tissue immunopositive for 8-OHdG and 4-HNE was reduced by 65% (P<0.002) and 66% (P<0.001), respectively, in ebselen-treated animals.

Conclusions—— Delayed (2-hour) treatment with intravenous ebselen significantly reduced gray and white matter damage and neurological deficit associated with transient ischemia. The reduction in tissue displaying evidence of oxidative stress suggests that the major mechanism of action is attenuation of free radical damage.

Key Words: antioxidants • free radicals • oxidative stress • stroke, experimental • white matter • rats

This article has been cited by other articles:

				H. Shen, C.-C. Kuo, J. Chou, A. Delvolve, S. N. Jackson, J. Post, A. S. Woods, B. J. Hoffer, Y. Wang, and B. K. Harvey Astaxanthin reduces ischemic brain injury in adult rats FASEB J, June 1, 2009; 23(6): 1958 - 1968. [Abstract] [Full Text] [PDF]

				P. N. Chander, O. Gealekman, S. V. Brodsky, S. Elitok, A. Tojo, M. Crabtree, S. S. Gross, and M. S. Goligorsky Nephropathy in Zucker Diabetic Fat Rat Is Associated with Oxidative and Nitrosative Stress: Prevention by Chronic Therapy with a Peroxynitrite Scavenger Ebselen J. Am. Soc. Nephrol., September 1, 2004; 15(9): 2391 - 2403. [Abstract] [Full Text] [PDF]

				M. T. Davis and W. J. Bartfay Ebselen Decreases Oxygen Free Radical Production and Iron Concentrations in the Hearts of Chronically Iron-Overloaded Mice Biol Res Nurs, July 1, 2004; 6(1): 37 - 45. [Abstract] [PDF]

				H. Matsue, D. Edelbaum, D. Shalhevet, N. Mizumoto, C. Yang, M. E. Mummert, J. Oeda, H. Masayasu, and A. Takashima Generation and Function of Reactive Oxygen Species in Dendritic Cells During Antigen Presentation J. Immunol., September 15, 2003; 171(6): 3010 - 3018. [Abstract] [Full Text] [PDF]

				P. A. Lapchak and J. A. Zivin Ebselen, a Seleno-Organic Antioxidant, Is Neuroprotective After Embolic Strokes in Rabbits: Synergism With Low-Dose Tissue Plasminogen Activator Stroke, August 1, 2003; 34(8): 2013 - 2018. [Abstract] [Full Text] [PDF]

				D. G. Herrera, A. G. Yague, S. Johnsen-Soriano, F. Bosch-Morell, L. Collado-Morente, M. Muriach, F. J. Romero, and J. M. Garcia-Verdugo Selective impairment of hippocampal neurogenesis by chronic alcoholism: Protective effects of an antioxidant PNAS, June 24, 2003; 100(13): 7919 - 7924. [Abstract] [Full Text] [PDF]

				R. Zhao and A. Holmgren A Novel Antioxidant Mechanism of Ebselen Involving Ebselen Diselenide, a Substrate of Mammalian Thioredoxin and Thioredoxin Reductase J. Biol. Chem., October 11, 2002; 277(42): 39456 - 39462. [Abstract] [Full Text] [PDF]

				R. Zhao, H. Masayasu, and A. Holmgren Ebselen: A substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thioredoxin oxidant PNAS, June 25, 2002; 99(13): 8579 - 8584. [Abstract] [Full Text] [PDF]

				J. McCulloch and D. Dewar A radical approach to stroke therapy PNAS, September 25, 2001; 98(20): 10989 - 10991. [Full Text] [PDF]